Company news and results Smith & Nephew, the global medical technology company, reported an increase in revenue of +10.3% in 2021. Outlook: Through our Strategy for Growth we are targeting consistent 4% to 6% underlying revenue growth by 2024, structurally ahead of historical levels, and a trading profit margin of at least 21% by 2024 with further improvements thereafter
Investing in Europe #58
Investing in Europe #58
Investing in Europe #58
Company news and results Smith & Nephew, the global medical technology company, reported an increase in revenue of +10.3% in 2021. Outlook: Through our Strategy for Growth we are targeting consistent 4% to 6% underlying revenue growth by 2024, structurally ahead of historical levels, and a trading profit margin of at least 21% by 2024 with further improvements thereafter